Multi-omics in HIV: searching insights to understand immunological non-response in PLHIV
暂无分享,去创建一个
E. Negredo | J. Mallolas | S. Fernández-Arroyo | F. Vidal | A. Rull | J. Peraire | C. Viladés | S. Chafino | S. Moreno | Beatriz Villar | Sonia Espineira | Marina Flores-Piñas | Sílvia Chafino
[1] B. Su,et al. Dysregulation of memory B cells and circulating T follicular helper cells is a predictor of poor immune recovery in HIV‐infected patients on antiretroviral therapy , 2023, Journal of medical virology.
[2] Fangzhou Song,et al. The diverse roles of miRNAs in HIV pathogenesis: Current understanding and future perspectives , 2023, Frontiers in Immunology.
[3] Jiyuan Zhang,et al. Distinct inflammation-related proteins associated with T cell immune recovery during chronic HIV-1 infection , 2022, Emerging microbes & infections.
[4] Fangzhou Song,et al. Single-cell sequencing resolves the landscape of immune cells and regulatory mechanisms in HIV-infected immune non-responders , 2022, Cell Death & Disease.
[5] Lanjing Zhang,et al. High-throughput proteomics: a methodological mini-review , 2022, Laboratory Investigation.
[6] E. Martinez,et al. Lipoprotein Profile in Immunological Non-Responders PLHIV after Antiretroviral Therapy Initiation , 2022, International journal of molecular sciences.
[7] Failure of CD4+ T-cell Recovery upon Virally-Effective cART: an Enduring Gap in the Understanding of HIV+ Immunological non-Responders. , 2022, The new microbiologica.
[8] D. Wishart,et al. Acylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials , 2022, Pharmacological Reviews.
[9] Chuanwu Zhu,et al. CD56dim NK Cell is an Important Factor in T Cell Depletion of cART-Treated AIDS Patients , 2022, International journal of general medicine.
[10] E. Li,et al. Guide to Metabolomics Analysis: A Bioinformatics Workflow , 2022, Metabolites.
[11] R. Sousa,et al. HLA-B*13, B*35 and B*39 Alleles Are Closely Associated With the Lack of Response to ART in HIV Infection: A Cohort Study in a Population of Northern Brazil , 2022, Frontiers in Immunology.
[12] M. Ghannoum,et al. Gut-derived bacterial toxins impair memory CD4+ T cell mitochondrial function in HIV-1 infection , 2022, The Journal of clinical investigation.
[13] Michael R Hamblin,et al. MicroRNA let-7 and viral infections: focus on mechanisms of action , 2022, Cellular & molecular biology letters.
[14] E. Negredo,et al. Adipokines as New Biomarkers of Immune Recovery: Apelin Receptor, RBP4 and ZAG Are Related to CD4+ T-Cell Reconstitution in PLHIV on Suppressive Antiretroviral Therapy , 2022, International journal of molecular sciences.
[15] W. Cao,et al. Comparative Transcriptional Analysis Identified Characteristic Genes and Patterns in HIV-Infected Immunological Non-Responders , 2022, Frontiers in Immunology.
[16] H. Shang,et al. Plasma MicroRNA Signature Panel Predicts the Immune Response After Antiretroviral Therapy in HIV-Infected Patients , 2021, Frontiers in Immunology.
[17] Haibo Ding,et al. The accumulation of plasma acylcarnitines are associated with poor immune recovery in HIV-infected individuals , 2021, BMC Infectious Diseases.
[18] R. Guimarães,et al. Brief Report: Polymorphisms in TNF-α/TNFR1 Pathway Genes Are Associated With CD4+ T-Cell Recovery in HIV-1–Infected Individuals on Antiretroviral Therapy , 2021, Journal of acquired immune deficiency syndromes.
[19] R. Rajasuriar,et al. HIV-Infected Individuals on ART With Impaired Immune Recovery Have Altered Plasma Metabolite Profiles , 2021, Open forum infectious diseases.
[20] S. Reus,et al. Impact of Advanced HIV Disease on Quality of Life and Mortality in the Era of Combined Antiretroviral Treatment , 2021, Journal of clinical medicine.
[21] D. Hazuda,et al. Microbiome and Metabolome driven differentiation of TGF-β producing Tregs leads to Senescence and HIV latency , 2020, bioRxiv.
[22] S. Lian,et al. The Impact of microRNA Regulation on Immune Recovery in HIV-1-Infected Patients Treated during Acute Infection: A Pilot Study , 2020, BioMed research international.
[23] M. Kummen,et al. Human Immunodeficiency Virus–Infected Immunological Nonresponders Have Colon-Restricted Gut Mucosal Immune Dysfunction , 2020, The Journal of infectious diseases.
[24] J. Mallolas,et al. High circulating SDF-1and MCP-1 levels and genetic variations in CXCL12, CCL2 and CCR5: Prognostic signature of immune recovery status in treated HIV-positive patients , 2020, EBioMedicine.
[25] Kinga Grabowska,et al. HIV and Proteomics: What We Have Learned from High Throughput Studies , 2020, Proteomics. Clinical applications.
[26] X. Correig,et al. Glycoprotein Profile Assessed by 1H-NMR as a Global Inflammation Marker in Patients with HIV Infection. A Prospective Study , 2020, Journal of clinical medicine.
[27] José Leandro Andrade-Santos,et al. CCR5 genotype and pre-treatment CD4+ T-cell count influence immunological recovery of HIV-positive patients during antiretroviral therapy. , 2020, Gene.
[28] Hao Wu,et al. Incomplete immune reconstitution in HIV/AIDS patients on antiretroviral therapy: Challenges of immunological non‐responders , 2020, Journal of leukocyte biology.
[29] T. Wiemken,et al. Plasma cysteine/cystine and glutathione/glutathione disulfide redox potentials in HIV and COPD patients. , 2019, Free radical biology & medicine.
[30] Anna V. Protasio,et al. Antagonism of PP2A is an independent and conserved function of HIV-1 Vif and causes cell cycle arrest , 2019, bioRxiv.
[31] J. Benito,et al. CD4 recovery is associated with genetic variation in IFNγ and IL19 genes. , 2019, Antiviral research.
[32] Mardge H. Cohen,et al. Genetic and clinical predictors of CD4 lymphocyte recovery during suppressive antiretroviral therapy: Whole exome sequencing and antiretroviral therapy response phenotypes , 2019, PloS one.
[33] M. Kankofer,et al. Is it useful to use several “omics” for obtaining valuable results? , 2019, Molecular Biology Reports.
[34] R. Gangakhedkar,et al. Incomplete functional T-cell reconstitution in immunological non-responders at one year after initiation of antiretroviral therapy possibly predisposes them to infectious diseases. , 2019, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[35] J. Benito,et al. Genetic variation in CCR2 and CXCL12 genes impacts on CD4 restoration in patients initiating cART with advanced immunesupression , 2019, PloS one.
[36] H. Garg,et al. TLR9 polymorphism correlates with immune activation, CD4 decline and plasma IP10 levels in HIV patients , 2019, BMC Infectious Diseases.
[37] J. Kinet,et al. Calcium signalling in T cells , 2019, Nature Reviews Immunology.
[38] T. Shirasaka,et al. Clinical characteristics of HIV-1-infected patients with high levels of plasma interferon-γ: a multicenter observational study , 2019, BMC Infectious Diseases.
[39] S. Elahi,et al. CD71+VISTA+ erythroid cells promote the development and function of regulatory T cells through TGF-β , 2018, PLoS biology.
[40] M. Lederman,et al. Cycling CD4+ T cells in HIV-infected immune nonresponders have mitochondrial dysfunction , 2018, The Journal of clinical investigation.
[41] Ruedi Aebersold,et al. Advancing translational research and precision medicine with targeted proteomics. , 2018, Journal of proteomics.
[42] B. Billah,et al. Polymorphism rs1385129 Within Glut1 Gene SLC2A1 Is Linked to Poor CD4+ T Cell Recovery in Antiretroviral-Treated HIV+ Individuals , 2018, Front. Immunol..
[43] K. Vijay. Toll-like receptors in immunity and inflammatory diseases: Past, present, and future , 2018, International Immunopharmacology.
[44] Ali Mobasheri,et al. Adipokines and inflammation: is it a question of weight? , 2018, British journal of pharmacology.
[45] N. Ford,et al. The Persistent Challenge of Advanced HIV Disease and AIDS in the Era of Antiretroviral Therapy , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[46] M. Clerici,et al. The NLRP3 Inflammasome Is Upregulated in HIV-Infected Antiretroviral Therapy-Treated Individuals with Defective Immune Recovery , 2018, Front. Immunol..
[47] X. Correig,et al. A baseline metabolomic signature is associated with immunological CD4+ T-cell recovery after 36 months of antiretroviral therapy in HIV-infected patients , 2017, AIDS.
[48] J. Blanco,et al. Higher levels of IL-6, CD4 turnover and Treg frequency are already present before cART in HIV-infected subjects with later low CD4 recovery. , 2017, Antiviral research.
[49] N. Srikant,et al. Incidence of Opportunistic Infections among HIV-Positive Adults on Highly Active Antiretroviral Therapy in a Teaching Hospital, India: Prospective Study , 2017, Journal of the International Association of Providers of AIDS Care.
[50] R. Diaz,et al. Plasma Metabolomics Biosignature According to HIV Stage of Infection, Pace of Disease Progression, Viremia Level and Immunological Response to Treatment , 2016, PloS one.
[51] S. Lewin,et al. Polymorphisms in the CD14 and TLR4 genes independently predict CD4+ T-cell recovery in HIV-infected individuals on antiretroviral therapy , 2016, AIDS.
[52] V. Dixit,et al. Inflammasomes: mechanism of assembly, regulation and signalling , 2016, Nature Reviews Immunology.
[53] F. Zadjali,et al. HLA-A68 and HLA-B15 alleles correlate with poor immune response among AIDS patients on combined antiretroviral therapy. , 2016, Human immunology.
[54] Mark R. Chance,et al. Proteome and Protein Network Analyses of Memory T Cells Find Altered Translation and Cell Stress Signaling in Treated Human Immunodeficiency Virus Patients Exhibiting Poor CD4 Recovery , 2016, Open forum infectious diseases.
[55] Clary B. Clish,et al. Metabolomics: an emerging but powerful tool for precision medicine , 2015, Cold Spring Harbor molecular case studies.
[56] P. Ciborowski,et al. Proteomics, biomarkers, and HIV‐1: A current perspective , 2015, Proteomics. Clinical applications.
[57] J. Rathmell,et al. The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function. , 2014, Cell metabolism.
[58] Magnus Rattray,et al. Relationship between genome and epigenome - challenges and requirements for future research , 2014, BMC Genomics.
[59] Aman Sharma,et al. High Producer Haplotype (CAG) of -863C/A, -308G/A and -238G/A Polymorphisms in the Promoter Region of TNF-α Gene Associate with Enhanced Apoptosis of Lymphocytes in HIV-1 Subtype C Infected Individuals from North India , 2014, PloS one.
[60] Cheng Huang,et al. MicroRNA-323-3p: a new biomarker and potential therapeutic target for rheumatoid arthritis , 2014, Rheumatology International.
[61] M. Ishii,et al. Sphingosine-1-Phosphate: a Master Regulator of Lymphocyte Egress and Immunity , 2014, Archivum Immunologiae et Therapiae Experimentalis.
[62] S. Lewin,et al. Increased glucose metabolic activity is associated with CD4+ T-cell activation and depletion during chronic HIV infection , 2014, AIDS.
[63] C. Richart,et al. Evaluation of the pharmacogenetics of immune recovery in treated HIV-infected patients , 2014, Expert opinion on drug metabolism & toxicology.
[64] M. Egger,et al. Hepatitis B virus infection is associated with impaired immunological recovery during antiretroviral therapy in the Swiss HIV cohort study. , 2013, The Journal of infectious diseases.
[65] J. Cosín,et al. European mitochondrial haplogroups are associated with CD4+ T cell recovery in HIV-infected patients on combination antiretroviral therapy. , 2013, The Journal of antimicrobial chemotherapy.
[66] M. Altfeld,et al. Control of human viral infections by natural killer cells. , 2013, Annual review of immunology.
[67] F. Ausubel. Metabolomics , 2012, Nature Biotechnology.
[68] Daniel Kolarich,et al. Glycomics, glycoproteomics and the immune system. , 2012, Current opinion in chemical biology.
[69] R. Maserati,et al. KIR-HLA Genotypes in HIV-Infected Patients Lacking Immunological Recovery despite Effective Antiretroviral Therapy , 2011, PloS one.
[70] F. Antunes,et al. Intracellular reactive oxygen species are essential for PI3K/Akt/mTOR-dependent IL-7-mediated viability of T-cell acute lymphoblastic leukemia cells , 2011, Leukemia.
[71] L. Montaner,et al. Metabolic and anthropometric parameters contribute to ART-mediated CD4+ T cell recovery in HIV-1-infected individuals: an observational study , 2011, Journal of the International AIDS Society.
[72] M. Clerici,et al. Immune activation, apoptosis, and Treg activity are associated with persistently reduced CD4+ T-cell counts during antiretroviral therapy , 2010, AIDS.
[73] J. Chmiel,et al. Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[74] Hong Yang,et al. Impact of hepatitis C viral replication on CD4+ T-lymphocyte progression in HIV–HCV coinfection before and after antiretroviral therapy , 2010, AIDS.
[75] A. d’Arminio Monforte,et al. Skewed T-cell maturation and function in HIV-infected patients failing CD4+ recovery upon long-term virologically suppressive HAART , 2010, AIDS.
[76] M. Watanabe,et al. Involvement of regulatory T cells in HIV immunopathogenesis. , 2010, Current HIV Research.
[77] H. Ullum,et al. T-Cell Dysfunction in HIV-1–Infected Patients With Impaired Recovery of CD4 Cells Despite Suppression of Viral Replication , 2010, Journal of acquired immune deficiency syndromes.
[78] S. Buttò,et al. HIV virology and pathogenetic mechanisms of infection: a brief overview. , 2010, Annali dell'Istituto superiore di sanita.
[79] P. Hunt. Th17, gut, and HIV: therapeutic implications , 2010, Current opinion in HIV and AIDS.
[80] D. Richman,et al. Gene expression before HAART initiation predicts HIV-infected individuals at risk of poor CD4+ T-cell recovery , 2010, AIDS.
[81] F. Marincola,et al. Let-7 microRNAs are developmentally regulated in circulating human erythroid cells , 2009, Journal of Translational Medicine.
[82] S. Franceschi,et al. Cancer risk in HIV-infected persons: influence of CD4(+) count. , 2009, Future oncology.
[83] S. Mummidi,et al. CCR5 Expression Levels Influence NFAT Translocation, IL-2 Production, and Subsequent Signaling Events during T Lymphocyte Activation1 , 2009, The Journal of Immunology.
[84] J. Goedert,et al. Mitochondrial DNA haplogroups influence AIDS progression , 2008, AIDS.
[85] S. Franceschi,et al. Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy , 2008, British journal of cancer.
[86] M. John,et al. HLA-Bw4 homozygosity is associated with an impaired CD4 T cell recovery after initiation of antiretroviral therapy. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[87] J. Goedert,et al. Polymorphisms of CUL5 Are Associated with CD4+ T Cell Loss in HIV-1 Infected Individuals , 2007, PLoS genetics.
[88] P. Harrigan,et al. Influence of polymorphisms within the CX3CR1 and MDR-1 genes on initial antiretroviral therapy response , 2003, AIDS.
[89] E. Rosenberg,et al. Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[90] T. Murakami,et al. Roles of chemokines and chemokine receptors in HIV-1 infection. , 2000, International journal of hematology.
[91] A. Torroni,et al. Classification of European mtDNAs from an analysis of three European populations. , 1996, Genetics.
[92] Marc Parmentier,et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene , 1996, Nature.
[93] F. Paltauf,et al. Ether lipids in biomembranes. , 1994, Chemistry and physics of lipids.
[94] H. Urlaub,et al. Quantitative Mass Spectrometry-Based Proteomics: An Overview. , 2021, Methods in molecular biology.
[95] C. Flanagan. Receptor conformation and constitutive activity in CCR5 chemokine receptor function and HIV infection. , 2014, Advances in pharmacology.
[96] Zhang-Zhi Hu,et al. Omics-based molecular target and biomarker identification. , 2011, Methods in molecular biology.
[97] C. Dosne Pasqualini. The HLA system. , 1979, Medicina.